Organization Profile

You just read:

Aeterna Zentaris: Poster to be Presented on the Design of Current ZoptEC Phase 3 Trial in Endometrial Cancer with Zoptarelin Doxorubicin at ASCO

News provided by

Aeterna Zentaris Inc.

May 22, 2014, 07:30 ET